Can You Take Orlistat and Mounjaro Together?

Why someone might consider taking both, and what that decision really involves

People who ask about taking orlistat and Mounjaro together usually fall into one of two situations. Either they are already taking orlistat and want to know whether Mounjaro can be added on top, or they are considering switching and wonder whether there is any reason to keep orlistat going during the transition. Both are reasonable questions, and neither has a simple yes-or-no answer.

Orlistat is a lipase inhibitor: it prevents roughly a third of the fat you eat from being digested and absorbed. It has a long track record in UK clinical practice and is available in prescription and lower-dose over-the-counter forms. Mounjaro, the brand name for tirzepatide, is a dual GIP and GLP-1 receptor agonist, the only medicine of its type licensed in the UK for weight management. You can read more about how tirzepatide works on the tirzepatide overview page.

The core of the decision is this: these two medicines do not interact in a pharmacologically dangerous way that has been documented in the prescribing literature, but that is very different from saying the combination is straightforward. A prescriber must weigh overlapping side-effect profiles, absorption concerns, and whether combining two weight-management medicines is appropriate for your health circumstances at all. The Mounjaro information page covers its licensed indications in full.

Overlapping side effects: the practical concern most people miss

Both medicines affect the gut, and that is where the practical problem sits. Mounjaro's most common side effects are gastrointestinal: nausea, vomiting, diarrhoea, constipation, indigestion. Orlistat has its own well-known GI profile, particularly oily stools, urgency, and loose bowel movements, effects that are directly tied to undigested fat passing through the gut. The NHS medicines guidance on orlistat sets out these effects clearly, and they are not trivial for many people.

Combining the two raises the realistic possibility that GI side effects become more frequent or more severe. Mounjaro is already titrated slowly, starting at 2.5 mg, specifically to give the gut time to adjust. Adding a medicine that reliably causes its own gut disruption on top of that could make the early weeks of treatment considerably harder to tolerate. That is not a theoretical concern, it is the kind of thing a prescriber considers when reviewing what you are already taking.

There is also an absorption question worth noting. Orlistat can reduce the absorption of fat-soluble vitamins and, in some cases, other medicines taken around the same time. Patients on orlistat are routinely advised to take a multivitamin. Whether the same timing considerations apply to tirzepatide specifically is something your prescriber would review against your medicine list. This is one reason why the full clinical picture of taking orlistat with Mounjaro matters more than a generic answer.

What a prescriber would actually consider before approving this combination

No published clinical trial has specifically examined tirzepatide and orlistat taken together, so there is no head-to-head data to quote. What prescribers work from is the individual SmPC for each medicine, knowledge of their respective mechanisms, and a review of the patient's current health, weight trajectory, and tolerance of existing treatment. The orlistat and Mounjaro combination page goes into the clinical framework in more detail.

In practice, most clinicians would not combine two weight-management medicines unless there was a specific clinical reason, the evidence base for Mounjaro alone is already strong. SURMOUNT-1 trial data showed average body-weight reductions of around 20–21% over 72 weeks at the highest dose, a result most clinicians would consider unlikely to be meaningfully improved by adding orlistat on top. For context, orlistat and Mounjaro are not in the same class of medicines at all, they are fundamentally different treatments from different eras of weight-management pharmacology.

If you are currently on orlistat and want to switch to Mounjaro, the typical approach is a clean transition: stop one before starting the other, with timing guided by your prescriber. If you are on Mounjaro and still find yourself reaching for orlistat capsules between doses, that is worth raising at your next clinical review rather than managing quietly. Our clinical team reviews every consultation individually, no automated decisions, just a real prescriber reading your answers the same day you submit them.

How to get a proper answer for your specific situation

The honest answer to the question of combining orlistat and tirzepatide together is: it depends, and the person who can tell you properly is a prescriber with access to your medical history. A forum thread or a Google result (including this one) cannot substitute for that. What this page can do is make sure you go into that conversation informed.

Key things to have ready: which medicine you are currently on and at what dose, how long you have been taking it, and what side effects you have experienced. If you are on any other medicines, that list matters too, because orlistat's interaction with fat-soluble substances means timing and sequencing can be relevant. You might also find it useful to read about Mounjaro alongside HRT if that applies to you, the absorption question comes up in that context as well.

At nume, we offer a free consultation reviewed by a GPhC-registered Independent Prescriber. If you are exploring Mounjaro as a next step and currently take orlistat, you can flag that in your consultation form and the prescriber will factor it in. Explore the weight-loss treatment options or check the weight-loss overview if you are still deciding which direction to go. There is no pressure, and the prescription decision will always sit with a clinician who has reviewed your full picture. Some people find it useful to browse the FAQs before they start, the answers on medicines and eligibility are written by the same prescribing team. That is it, really: get the right information, then get a clinical opinion.